• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Health Sciences (Health-Sciences)
    • School of Health Sciences (Health-Sciences) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Health Sciences (Health-Sciences)
    • School of Health Sciences (Health-Sciences) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Non-linear mixed effects modeling of liver function biomarkers in TB-HIV patients co-treated with Rifampicin and Efavirenz based regimens

    Thumbnail
    View/Open
    Masters thesis (1.631Mb)
    Abstract (212.8Kb)
    Date
    2013-11
    Author
    Bisaso, Kuteesa Ronald
    Metadata
    Show full item record
    Abstract
    Introduction Survival has improved as a result of improved HIV therapy but liver disease remains a critical problem in HIV patients. HIV disease, ART and Tuberculosis treatments have all been documented to cause liver damage, but no published study on the ultimate subclinical effect of treatment on the liver. Objectives To develop a mechanistic PK/PD model to characterize liver functional changes in HIV patients on EFV based HAART with or without TB treatment. Materials and Methods CYP2B6*6 & 11, CYP3A5 and ABCB1 genotypes, baseline age and weight, plasma Efavirenz, Creatinine, Albumin and ALT data were collected at specified times for 3 months from 262 HIV patients on EFV based HAART, of which 158 were on Rifampicin based anti-TB treatment for TB co-infection. A semi-mechanistic model based describing changes in plasma albumin concentration during treatment with HAART was developed and fit to the data using the laplacian method in NONMEM software version 7.2 and covariate analysis was done. Results and conclusions The model had three fixed and two random effects parameters. It had a mean prediction error of 0.97% and precision of 87.13%. TB disease status and ABCB1c.3435C>T genotype were significant covariates (p<0.01). Albumin secretion rate in HIV patients was 39% lower at the start of HAART treatment and predicted to improve to approximately 84% of that reported in normal people over a 3 month treatment period. TB co-infection worsens the liver dysfunction caused by HIV. ABCB1c.3435C>T genotype is a predictor of the level of improvement in the rate of secretion of Albumin by the liver during treatment with HAART.
    URI
    http://hdl.handle.net/10570/2848
    Collections
    • School of Health Sciences (Health-Sciences) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV